1. Hypoglycemic Effect of Opuntia ficus-indica var. saboten Is Due to Enhanced Peripheral Glucose Uptake through Activation of AMPK/p38 MAPK Pathway
- Author
-
Hye Kyung Kim, Young-Tae Hahm, Myung-Gyou Kim, and Kang-Hyun Leem
- Subjects
0301 basic medicine ,AMPK ,Male ,medicine.medical_treatment ,Glucose uptake ,AMP-Activated Protein Kinases ,db/db mice ,p38 Mitogen-Activated Protein Kinases ,Myoblasts ,Mice ,AMP-activated protein kinase ,Insulin ,Mice, Inbred ICR ,Nutrition and Dietetics ,Glucose Transporter Type 4 ,biology ,Microvilli ,Opuntia ,Jejunum ,lcsh:Nutrition. Foods and food supply ,medicine.medical_specialty ,Cell Survival ,lcsh:TX341-641 ,p38 MAPK ,Article ,Cell Line ,Diabetes Mellitus, Experimental ,03 medical and health sciences ,Insulin resistance ,Internal medicine ,medicine ,Animals ,Opuntia ficus-indica var. saboten ,Plant Extracts ,glucose uptake ,GLUT4 ,L6 myoblasts ,Quantitative insulin sensitivity check index ,Glucose transporter ,alpha-Glucosidases ,medicine.disease ,Rats ,Mice, Inbred C57BL ,030104 developmental biology ,Endocrinology ,Glucose ,Gene Expression Regulation ,biology.protein ,Food Science - Abstract
Opuntia ficus-indica var. saboten (OFS) has been used in traditional medicine for centuries to treat several illnesses, including diabetes. However, detailed mechanisms underlying hypoglycemic effects remain unclear. In this study, the mechanism underlying the hypoglycemic activity of OFS was evaluated using in vitro and in vivo systems. OFS treatment inhibited α-glucosidase activity and intestinal glucose absorption assessed by Na+-dependent glucose uptake using brush border membrane vesicles. AMP-activated protein kinase (AMPK) is widely recognized as an important regulator of glucose transport in skeletal muscle, and p38 mitogen-activated protein kinase (MAPK) has been proposed to be a component of AMPK-mediated signaling. In the present study, OFS dose-dependently increased glucose uptake in L6 muscle cells. The AMPK and p38 MAPK phosphorylations were stimulated by OFS, and inhibitors of AMPK (compound C) and p38 MAPK (SB203580) abolished the effects of OFS. Furthermore, OFS increased glucose transporter 4 (GLUT4) translocation to the plasma membrane. OFS administration (1 g/kg and 2 g/kg body weight) in db/db mice dose-dependently ameliorated hyperglycemia, hyperinsulinemia, and glucose tolerance. Insulin resistance assessed by homeostasis model assessment of insulin resistance and quantitative insulin sensitivity check index were also dose-dependently improved with OFS treatment. OFS administration improved pancreatic function through increased β-cell mass in db/db mice. These findings suggest that OFS acts by inhibiting glucose absorption from the intestine and enhancing glucose uptake from insulin-sensitive muscle cells through the AMPK/p38 MAPK signaling pathway.
- Published
- 2016